Mitchell B. Lowenstein

1.6k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Mitchell B. Lowenstein is a scholar working on Rheumatology, Genetics and Immunology. According to data from OpenAlex, Mitchell B. Lowenstein has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Genetics and 6 papers in Immunology. Recurrent topics in Mitchell B. Lowenstein's work include Systemic Lupus Erythematosus Research (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Vasculitis and related conditions (3 papers). Mitchell B. Lowenstein is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Vasculitis and related conditions (3 papers). Mitchell B. Lowenstein collaborates with scholars based in United States, Australia and Argentina. Mitchell B. Lowenstein's co-authors include Matija Tomšič, Andrea Calvo, Jianhui Gu, Thasia Woodworth, Juan J. Gómez‐Reino, Emma Alecock, Daniel Siri, Anthony Sebba, Graeme Jones and M. C. Genovese and has published in prestigious journals such as JAMA, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Mitchell B. Lowenstein

17 papers receiving 1.0k citations

Hit Papers

Comparison of tocilizumab monotherapy versus methotrexate... 2009 2026 2014 2020 2009 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell B. Lowenstein United States 10 732 343 284 201 196 19 1.1k
Andrew R. Baldassare United States 12 402 0.5× 295 0.9× 151 0.5× 187 0.9× 206 1.1× 19 829
J. Box United States 7 763 1.0× 367 1.1× 356 1.3× 217 1.1× 163 0.8× 10 1.1k
K Steinsson Iceland 19 628 0.9× 401 1.2× 150 0.5× 82 0.4× 193 1.0× 35 928
Leonor Barile-Fabris Mexico 13 815 1.1× 415 1.2× 145 0.5× 111 0.6× 148 0.8× 30 1.2k
Loukas Settas Greece 16 819 1.1× 349 1.0× 358 1.3× 134 0.7× 255 1.3× 28 1.2k
L Pallarés Spain 16 842 1.2× 457 1.3× 151 0.5× 53 0.3× 165 0.8× 26 1.1k
Stefania Sacco Italy 13 502 0.7× 264 0.8× 176 0.6× 211 1.0× 134 0.7× 20 958
M. N. Manoussakis Greece 17 620 0.8× 314 0.9× 132 0.5× 50 0.2× 227 1.2× 22 1.1k
Yehuda Shoenfeld Israel 17 949 1.3× 612 1.8× 280 1.0× 51 0.3× 198 1.0× 32 1.3k
Piersandro Riboldi Italy 20 1.0k 1.4× 546 1.6× 121 0.4× 430 2.1× 522 2.7× 50 1.5k

Countries citing papers authored by Mitchell B. Lowenstein

Since Specialization
Citations

This map shows the geographic impact of Mitchell B. Lowenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell B. Lowenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell B. Lowenstein more than expected).

Fields of papers citing papers by Mitchell B. Lowenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell B. Lowenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell B. Lowenstein. The network helps show where Mitchell B. Lowenstein may publish in the future.

Co-authorship network of co-authors of Mitchell B. Lowenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell B. Lowenstein. A scholar is included among the top collaborators of Mitchell B. Lowenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell B. Lowenstein. Mitchell B. Lowenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cohen, Stanley, Peter S. Roland, Angela G. Shoup, et al.. (2010). A Pilot Study of Rituximab in Immune-Mediated Inner Ear Disease. Audiology and Neurotology. 16(4). 214–221. 33 indexed citations
2.
Jones, Graeme, Anthony Sebba, Jianhui Gu, et al.. (2009). Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the Rheumatic Diseases. 69(1). 88–96. 609 indexed citations breakdown →
3.
Genovese, Mark C., Jeffrey Kaine, Mitchell B. Lowenstein, et al.. (2008). Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging study. Arthritis & Rheumatism. 58(9). 2652–2661. 157 indexed citations
4.
Kanik, Keith S., et al.. (1997). Polymyalgia Rheumatica with a Low Erythrocyte Sedimentation Rate. JCR Journal of Clinical Rheumatology. 3(6). 319–323. 5 indexed citations
5.
Lowenstein, Mitchell B., et al.. (1983). Increased frequency of hla‐dr3 and dr4 in polymyalgia rheumatica‐giant cell arteritis. Arthritis & Rheumatism. 26(7). 925–927. 31 indexed citations
6.
Bocanegra, Tomás S., Bernard F. Germain, S. R. Saba, et al.. (1982). In vitro cytotoxicity of human endothelial cells in polymyalgia rheumatica and giant cell arteritis. Rheumatology International. 2(3). 133–136. 9 indexed citations
7.
Espinoza, Luis R., et al.. (1982). Polymyalgia rheumatica and giant cell arteritis: circulating immune complexes.. PubMed. 9(4). 556–60. 22 indexed citations
8.
McLean, Robert H., et al.. (1980). Familial partial deficiency of the third component of complement (C3) and the hypocomplementemic cutaneous vasculitis syndrome. The American Journal of Medicine. 68(4). 549–558. 30 indexed citations
9.
Abeles, Micha, Jeffrey D. Urman, Arthur Weinstein, Mitchell B. Lowenstein, & Naomi F. Rothfield. (1980). Systemic lupus erythematosus in the younger patient: survival studies.. PubMed. 7(4). 515–22. 39 indexed citations
10.
Lowenstein, Mitchell B., et al.. (1980). Polymyalgia rheumatica and giant cell arthritis: histocompatibility typing and hepatitis‐B infection studies. Arthritis & Rheumatism. 23(4). 516–518. 24 indexed citations
11.
Ballow, Mark, Robert H. McLean, Ivan Damjanov, & Mitchell B. Lowenstein. (1979). Immunologic reconstitution, autoimmunity, and T-cell immune deficiencies. Cellular Immunology. 45(2). 364–376. 9 indexed citations
12.
Urman, Jeffrey D., Mitchell B. Lowenstein, Micha Abeles, & Arthur Weinstein. (1978). Oral mucosal ulceration in systemic lupus erythematosus. Arthritis & Rheumatism. 21(1). 58–61. 57 indexed citations
13.
Lowenstein, Mitchell B., et al.. (1978). Existence of Sporothrix schenckii as a Pulmonary Saprophyte. CHEST Journal. 73(3). 419–421. 9 indexed citations
14.
Lowenstein, Mitchell B. & Naomi F. Rothfield. (1977). Family Study of Systemic Lupus Erythematosus. Arthritis & Rheumatism. 20(7). 1293–1303. 32 indexed citations
15.
Lowenstein, Mitchell B.. (1977). Skin Immunofluorescence in Infective Endocarditis. JAMA. 238(11). 1163–1163. 9 indexed citations
16.
Lowenstein, Mitchell B.. (1977). Skin immunofluorescence in infective endocarditis. JAMA. 238(11). 1163–1165.
17.
Weinstein, Andrew L., et al.. (1977). The chondrocalcinosis--pseudogout syndrome. (calcium pyrophosphate dihydrate deposition disease).. PubMed. 41(11). 693–5. 1 indexed citations
18.
McLean, R H, Mitchell B. Lowenstein, & N Rothfield. (1977). HETEROZYGOUS C3 DEFICIENCY ASSOCIATED WITH A SYSTEMIC LUPUS ERYTHEMATOSUS-LIKE DISEASE. Pediatric Research. 11(4). 490–490. 8 indexed citations
19.
Lowenstein, Mitchell B.. (1975). Osteopathic theories and practice.. PubMed. 102(1). 25–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026